All Pharma articles – Page 26
-
NewsWarning over buying drugs online
The purchase of prescription medicines online without a prescription is increasing, pharmacists have said.
-
NewsSchizophrenia report demands better care
Significant improvements in care are needed if the lives of schizophrenia sufferers are to get better, according to the first national audit for people with the severe mental illness.
-
NewsGP nominated as new NICE chair
One of the country’s most prominent GPs has been named as the government’s preferred candidate to chair the National Institute for Health and Clinical Excellence.
-
NewsDrug chief uncomfortable over fund
A cash pot used to pay for life-extending drugs should not be limited to patients who have cancer, the head of the National Institute for Health and Clinical Excellence has suggested.
-
NewsPatients should pay for 'lifestyle' diseases - Tory MP
Patients suffering from diseases caused by “lifestyle choices” such as diabetes should pay for their medication to help save the NHS from collapse, a Tory GP has urged.
-
NewsQIPP lead: drugs bill will increase
Providers and commissioners need to focus on making sure they achieve value for money on drugs rather than cutting overall spend, the government’s pharmaceutical spending efficiency expert has told HSJ.
-
NewsReport: NHS slipping on Innovation, Health and Wealth targets
There has been a “disappointing” lack of local engagement with the government’s plan to improve the spread of innovation in the NHS, new research has concluded.
-
NewsMedicines body review announced
Concerns about the inconsistent availability of some medicines in Scotland has prompted a review of the decision-making process at the NHS’s drugs approval body.
-
SupplementsDrug action - an HSJ supplement on primary care
From recruitment challenges to a greater role for pharmacies, our supplement probes the latest developments in primary care
-
HSJ KnowledgeWhy pharmacies must think big
If pharmacists fail to grasp the opportunities before them, someone else will
-
HSJ KnowledgeDispense with the old way of doing things
Lack of transparency in the medicines supply chain is of concern to many observers
-
NewsQIPP medicines management schemes get green light
QIPP plans to reduce spending on medicines are making better progress than other major workstreams.
-
NewsGovernment rejects BMA's rationing warning
The government has rejected a warning by the new leader of Britain’s doctors that the health of NHS patients was being put at risk because they were being denied access to operations and drugs.
-
NewsCall to maintain Cancer Drugs Fund
Tens of thousands of cancer sufferers could be denied life-extending drugs unless the government finds a way to continue funding treatment for patients, a charity has warned.
-
HSJ KnowledgeStepping good practice up a gear
HIECs are invaluable in delivering improvement at scale and pace
-
HSJ Local
Commissioners report Lucentis pressure from Newcastle FT
FINANCE: North Tyneside PCT, Northumberland CT and Newcastle PCT are facing overspending risks in relation to Newcastle upon Tyne Hospitals Foundation Trust, largely attributable to use of Lucentis (ranibizumab injection).
-
NewsNicholson orders trusts to offer approved drugs
All NHS organisations have been ordered to publish details of which drugs they will routinely fund in a bid to make sure patients get medicines they are legally entitled to.
-
HSJ KnowledgePatients 'should take trusts to court' over drug access
‘Numerous trusts are acting unlawfully… denying patients an innovative and cost-effective treatment,’ writes NICE chair Sir Michael Rawlins in a recent HSJ article. Read the article, listen to the BBC’s follow-up and share your views.
-
NewsGames drug testing labs to become research centre
A £10m scientific research centre is to be based on the site of Olympic drug testing laboratories, David Cameron has announced.
-
NewsSHIP cluster U-turns on Lucentis policy after price is slashed
A primary care trust cluster under the threat of legal action for recommending the use of an unlicensed drug has revoked the policy after the pharmaceutical company cut the price of the medicine.